CV Sciences stockholders elect directors, ratify auditor, approve exec comp at 2024 annual meeting

CV Sciences, Inc.

Quorum of 53.1% achieved with 86,682,380 shares represented at June 3, 2024 meeting.
Three directors elected: Dr. Jamie Corroon (28,999,412 for), Joseph Dowling (26,074,685 for), Bill McCorkle (28,764,821 for).
Ratification of Haskell & White LLP as auditor for FY2024 passed with 84,248,548 for, 1,837,030 against.
Non-binding advisory vote on named executive officer compensation approved with 20,844,946 for, 9,562,945 against.
All proposals passed with broker non-votes on director elections and say-on-pay.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.